TissueGen, Inc.

TissueGen^® Inc. is the developer of ELUTE^® fiber, a groundbreaking biodegradable fiber format for advanced drug delivery, nerve regeneration, and tissue engineering. TissueGen has more than four decades of cumulative experience in extruding biodegradable polymer fibers with broad drug delivery capabilities. ELUTE fiber can directly replace standard fibers used in biodegradable textiles currently on the market and provide significantly improved clinical outcomes by delivering therapeutic agents directly at the site of the implant.  By delivering drugs and growth factors at the site of implantation, ELUTE fiber enables medical devices to guide the body’s healing and regenerative processes.